Nasdaq smmt.

Nov 8, 2023 · The public float for SMMT is 111.75M, and currently, short sellers hold a 9.57% ratio of that floaft. The average trading volume of SMMT on November 08, 2023 was 1.02M shares. SMMT) stock’s latest price update. Summit Therapeutics Inc (NASDAQ: SMMT)’s stock price has plunge by -12.16relation to previous closing price of 2.18. Summit Therapeutics Inc (NASDAQ:SMMT) 1.93 Delayed Data As of Nov 17 +0.07 / +3.76% Today’s Change 0.66 Today ||| 52-Week Range 5.78 -54.59% Year-to-Date Quote Profile News Charts Forecasts...OXFORD, United Kingdom, April 26, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Summit Therapeutics Inc NASDAQ: SMMT is a biopharmaceutical company focused on discovering, developing, and commercializing antibiotics for serious infectious ...

Nasdaq | SMMT U.S.: Nasdaq Summit Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 27, 2023 6:38 a.m. EST Delayed quote $ 2.0600 0.06 …Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Based on a thorough review of the design and enrollment status of two ongoing blinded Phase III Ri-CoDIFy trials, Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it will combine its two blinded pivotal Phase III clinical trials evaluating ridinilazole versus …

Principal Financial Group Inc. purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 13,679 shares of the company’s stock, valued at approximately $34,000. A number of other […]

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) the drug discovery and development company advancing therapies for Duchenne muscular ...Nasdaq | SMMT U.S.: Nasdaq Summit Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 27, 2023 6:38 a.m. EST Delayed quote $ 2.0600 0.06 …Cambridge, Massachusetts, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced the postponement of its previously announced ...WebShare Price. NASDAQ: SMMT. 2.25USD 0.12. At 04/12/2023 19:25. More information. SEC Filings. Current report filing. VIEW FILING. Quarterly report pursuant to ...

Oxford, UK, and Cambridge, MA, US, 27 March 2019 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today reports its financial results for the ...

Oxford, UK, and Cambridge, MA, US, 24 December 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces the exercise by Leopoldo Zambeletti, a Non-Executive Director of Summit, of ...

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that the first United States-based patient has been enrolled in the Phase III HARMONi study. HARMONi is a Phase III multiregional, randomized, double-blinded study. The study will evaluate the efficacy and safety of ivonescimab combined …Phunware Inc (NASDAQ:PHUN) has a beta value of 10.36 and has seen 4.58 million shares traded in the recent trading session. The company, currently valued at $19.34M, closed the recent trade at $0.14 per share which meant it gained $0.01 on the day or 13.69% during that session. The PHUN stock price ...WebOxford, UK, and Cambridge, MA, US, 19 December 2019 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), a leader in antibiotic innovation, announces that, further to the announcement made on 6 ...(NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its third quarter 2023 financial results and provide an operational ...Simply Wall St. Insider Monkey. Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 16, 2023 · The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97. Summit Therapeutics Inc (NASDAQ:SMMT) 1.93 Delayed Data As of Nov 17 +0.07 / +3.76% Today’s Change 0.66 Today ||| 52-Week Range 5.78 -54.59% Year-to-Date Quote Profile News Charts Forecasts...Nov 27, 2023 · 78% of the company is held by a single shareholder (Robert Duggan) Insiders have been buying lately. If you want to know who really controls Summit Therapeutics Inc. ( NASDAQ:SMMT ), then you'll ... Dec 1, 2023 · Which Summit Therapeutics insiders have been buying company stock? The following insiders have purchased SMMT shares in the last 24 months: Ankur Dhingra ($217,390.39), Mahkam Zanganeh ($16,772,430.15), Manmeet Singh Soni ($4,999,999.20), and Robert W Duggan ($487,318,100.91). Cambridge, Massachusetts, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced the postponement of its previously announced ...WebNov 30, 2023 · The latest price target for Summit Therapeutics ( NASDAQ: SMMT) was reported by HC Wainwright & Co. on Wednesday, November 18, 2020. The analyst firm set a price target for 0.00 expecting SMMT to ... Summit Therapeutics Inc. (NASDAQ:SMMT) insiders placed bullish bets worth US$62m in the last 12 months. (Simply Wall St.) Mar-17-22 04:14PM. Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021. (GlobeNewswire) +7.93%.

MENLO PARK, Calif.--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it is nearing the previously-announced expiration date for its rights offering of 5:00 pm Eastern Time on March 1, 2023 (the “Expiration Date”).As a reminder, the subscription price per share …Web

Oxford, UK, and Cambridge, MA, US, 24 December 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces the exercise by Leopoldo Zambeletti, a Non-Executive Director of Summit, of ...há 10 horas ... Price Performance Review of SMMT. On Friday, Summit Therapeutics Inc [NASDAQ:SMMT] saw its stock jump 4.93% to $2.13. On the same session, the ...Aug 20, 2022 · Those following along with Summit Therapeutics Inc. (NASDAQ:SMMT) will no doubt be intrigued by the recent purchase of shares by Robert Duggan, Co-CEO & Executive Chairman of the company, who ... Lihat chart Summit Therapeutics Inc. live untuk melacak pergerakan harga sahamnya. Temukan prediksi pasar, berita finansial dan pasar dari SMMT.Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.Oxford, UK, and Cambridge, MA, US, 14 April 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that Mr Robert (Bob) Duggan has been appointed Chief Executive Officer (‘CEO’) of ...Investors eyeing a purchase of Summit Therapeutics Inc (Symbol: SMMT) stock, but cautious about paying the going market price of $2.52/share, might benefit from considering selling puts among the ...Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week Read full article Simply Wall St

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebSummit Therapeutics Inc. Common Stock (SMMT) Nasdaq Listed. DATA AS OF Nov 26, 2021. 0. Add to Watchlist. Add to Portfolio. SMMT SMMT HISTORICAL DATA. Aug 20, 2022 · Those following along with Summit Therapeutics Inc. (NASDAQ:SMMT) will no doubt be intrigued by the recent purchase of shares by Robert Duggan, Co-CEO & Executive Chairman of the company, who ... Aug 2, 2023 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California , and we have additional offices in Oxford, UK ... (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its third quarter 2023 financial results and provide an operational ...Summit Therapeutics (NASDAQ: SMMT ) announced during its Third Quarter 2023 Earnings and Update Call that it has started enrolling for the second Phase III clinical trial for ivonescimab, a potential treatment for non-small cell lung cancer. The company also introduced its new Chief Operating Officer, Manmeet Soni, who has made a $5 million …WebSummit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.(NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational prog... 26 days ago - ...Summit Therapeutics Inc (NASDAQ:SMMT) trade information. Upright in the green during last session for gaining 3.76%, in the last five days SMMT remained trading in the green while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $1.93 price level, adding 5.85% to its value on the day.Source: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

SMMT Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. / Nasdaq | SMMT U.S.: Nasdaq Summit Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 27, 2023 6:38 a.m. EST Delayed quote $ 2.0600 0.06 3.00% Before Hours... Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.Instagram:https://instagram. best prop firms 2023tlss stock forecastpbw etfave villas OXFORD, United Kingdom, Sept. 24, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ... uber stock predictionishares 20+ year treasury bond etf Summit Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SMMT updated stock price target summary.Oxford, UK, and Cambridge, MA, US, 27 March 2019 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today reports its financial results for the ... best tax software for day traders Cambridge, Massachusetts, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on ...WebCEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company’s product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical ...OXFORD, United Kingdom, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...